Pacira BioSciences, Inc. (PCRX)
Financial leverage ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 1,553,520 | 1,521,690 | 1,646,820 | 1,583,320 | 1,574,390 | 1,534,460 | 1,542,380 | 1,523,420 | 1,681,200 | 1,734,360 | 1,733,990 | 1,891,480 | 2,075,350 | 1,356,000 | 1,325,830 | 1,287,550 | 1,274,510 | 1,220,270 | 866,111 | 821,379 |
Total stockholders’ equity | US$ in thousands | 778,348 | 749,583 | 879,278 | 892,162 | 870,130 | 831,551 | 807,975 | 768,041 | 775,010 | 770,123 | 756,636 | 709,576 | 730,408 | 718,602 | 687,168 | 650,818 | 619,688 | 584,690 | 388,148 | 374,037 |
Financial leverage ratio | 2.00 | 2.03 | 1.87 | 1.77 | 1.81 | 1.85 | 1.91 | 1.98 | 2.17 | 2.25 | 2.29 | 2.67 | 2.84 | 1.89 | 1.93 | 1.98 | 2.06 | 2.09 | 2.23 | 2.20 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,553,520K ÷ $778,348K
= 2.00
The financial leverage ratio of Pacira BioSciences, Inc. has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The ratio measures the company's reliance on debt financing compared to equity.
The ratio started at 2.20 on March 31, 2020, indicating higher debt levels relative to equity. Over the next few quarters, the ratio increased slightly before showing a declining trend. By March 31, 2021, the ratio had decreased to 1.98, indicating a reduction in debt relative to equity.
From March 31, 2021, to June 30, 2022, the financial leverage ratio continued to decrease steadily, reaching a low of 1.77 by March 31, 2024. This decline suggests the company was reducing its debt levels compared to equity, which can be a positive sign for investors concerned about financial risk.
However, the ratio saw a slight increase in the subsequent quarters, reaching 2.00 by December 31, 2024. This uptick indicates a slight increase in debt levels compared to equity, which could be a signal that the company is taking on more debt for potential growth or investment opportunities.
Overall, the financial leverage ratio of Pacira BioSciences, Inc. has shown variability over the analyzed period, with fluctuations in the company's debt-to-equity structure impacting its financial leverage position. Investors and analysts may want to closely monitor this ratio to assess the company's financial risk and capital structure strategy.
Peer comparison
Dec 31, 2024